Intravenous Immune Globulin Products
Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, IVIG is administered intravenously and is used primarily to treat three categories of illnesses: immune deficiencies, autoimmune neuromuscular disorders and certain neurological disorders.
Nufactor carries the following F.D.A.-approved immune globulin products:
* denotes that Nufactor does not currently carry this product.
Product
Manufacturer
FDA-Approved Indication
INTRAVENOUS IMMUNE GLOBULIN (IVIG)
Product: Carimune® NF
Manufacturer: CSL Behring
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD),
Immune Thrombocytopenic Purpura (ITP)
Product: Flebogamma® DIF 5%
Manufacturer: Grifols
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: Flebogamma® DIF 10%
Manufacturer: Grifols
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAGARD S/D
Manufacturer: Shire
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD),
Chronic Lymphocytic Leukemia (CLL),
Immune Thrombocytopenic Purpura (ITP),
Kawasaki Disease
Product: GAMMAGARD S/D (IGA<1 MCG/ML)
Manufacturer: Shire
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD),
Chronic Lymphocytic Leukemia (CLL),
Immune Thrombocytopenic Purpura (ITP),
Kawasaki Disease
Product: GAMMAGARD LIQUID
Manufacturer: Shire
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAKED™
Manufacturer: Kedrion
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD),
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Immune Thrombocytopenic Purpura (ITP)
Product: Gammaplex® 5%
Manufacturer: Bio Products Laboratory
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: Gammaplex® 10%
Manufacturer: Bio Products Laboratory
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: Gamunex®-C
Manufacturer: Grifols
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD),
Immune Thrombocytopenic Purpura (ITP),
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Product: Octagam® 5%
Manufacturer: Octapharma
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: Octagam® 10%
Manufacturer: Octapharma
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Product: PANZYGA®
Manufacturer: CSL Behring
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Adult Immune Thrombocytopenic Purpura (ITP)
Product: Privigen®
Manufacturer: CSL Behring
FDA-Approved Indication:
Primary Immunodeficiency Diseases (PIDD)
Immune Thrombocytopenic Purpura (ITP)
